NRC Health
NRC | NASDAQ
$24.25
+$0.42 (+1.76%)
Nov 2, 2026, 10:34 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 137.39M | 143.06M | 148.58M | 151.57M | 147.95M | 133.28M |
Cost of Revenue | 60M | 56.93M | 56.02M | 57.05M | 52.35M | 49.19M |
Gross Profit | 77.4M | 86.13M | 92.57M | 94.52M | 95.6M | 84.09M |
Operating Income | 22.59M | 35.19M | 40.05M | 46.54M | 50.27M | 42.68M |
Interest Income | 111K | 125K | 820K | 168K | 14K | 18K |
Pretax Income | 17.84M | 32.69M | 39.96M | 42.82M | 48.62M | 41.47M |
Net Income | 11.6M | 24.78M | 30.97M | 31.8M | 37.47M | 37.26M |
Selling & General & Admin | 54.81M | 44.91M | 46.58M | 42.7M | 38.96M | 34.44M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 6.02M | 5.94M | 5.28M | 6.37M | 7.03M |
Operating Expenses | 54.81M | 50.93M | 52.52M | 47.98M | 45.33M | 41.41M |
Interest Expense | 4.76M | 2.6M | 862K | 1.21M | 1.67M | 1.81M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 114.8M | 107.87M | 108.54M | 105.03M | 97.68M | 90.6M |
Income Tax Expense | 6.24M | 7.91M | 8.99M | 11.02M | 11.16M | 4.21M |
Shares Outstanding (Basic) | 22.38M | 23.72M | 24.54M | 24.92M | 25.42M | 25.17M |
Shares Outstanding (Diluted) | 22.4M | 23.74M | 24.67M | 25.05M | 25.64M | 25.7M |
EPS (Basic) | 0.52 | 1.05 | 1.26 | 1.28 | 1.47 | 1.48 |
EPS (Diluted) | 0.52 | 1.04 | 1.25 | 1.27 | 1.46 | 1.45 |
EBITDA | 30.23M | 41.31M | 45.99M | 49.3M | 56.66M | 50.79M |
EBIT | 22.61M | 35.29M | 40.09M | 44.02M | 50.29M | 43.28M |
Depreciation & Amortization | 7.62M | 6.02M | 5.9M | 5.28M | 6.37M | 7.51M |
Add to Watchlist
Select watchlists to add or remove NRC